Stockreport

Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF MIAMI, April 22, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:  OPK) today provided an update on two abstracts regarding the global Phase 3 somatrogon pediatric [Read more]